FRESENIUS TRIAL GROUP (100 LIDÍ) ATG

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

2009 | Faculty of Medicine in Hradec Králové

FRESENIUS TRIAL GROUP (100 LIDÍ) ATG

Publication